A new study shows that an alpha-particle emitting radiopeptide — radioactive material bound to a synthetic peptide, a component of protein — is effective for treating prostate cancer in mice, according to researchers.
A new study shows that an alpha-particle emitting radiopeptide — radioactive material bound to a synthetic peptide, a component of protein — is effective for treating prostate cancer in mice, according to researchers.